1358 Novel EGFR/PI3K dual-targeting nanoparticles induce immunogenic cell death in bladder cancer | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Regular and Young Investigator Award Abstracts

Novel Single-Agent Immunotherapies

1358 Novel EGFR/PI3K dual-targeting nanoparticles induce immunogenic cell death in bladder cancer

Online download statistics by month:

Online download statistics by month: November 2022 to August 2024

	Abstract	Full	Pdf
Nov 2022	254	0	18
Dec 2022	54	0	13
Jan 2023	56	0	1
Feb 2023	40	0	4
Mar 2023	34	0	7
Apr 2023	16	0	11
May 2023	22	0	3
Jun 2023	10	0	1
Jul 2023	16	0	6
Aug 2023	6	0	3
Sep 2023	6	0	1
Oct 2023	12	0	0
Nov 2023	24	0	1
Dec 2023	28	0	5
Jan 2024	18	0	2
Feb 2024	22	0	5
Mar 2024	36	0	20
Apr 2024	16	0	8
May 2024	12	0	2
Jun 2024	12	0	3
Jul 2024	8	0	5
Aug 2024	12	0	2
Total	714	0	121